I had become aware of Flatiron around 2018, and I was excited about their potential. At that time, I was researching on an EMR platform (and I did create a model for a company). My ideas never came to fruition because it got complicated by a set of external circumstances beyond my control, but well, … Continue reading Drugmakers get hooked on data →